Currently there are no upcoming events.
CRI's Samik Upadhaya, Ph.D., speaks on the "Biomarkers in IO: Challenges and Putative Benefits of Multi-omics Technologies" panel on February 25.
CRI's Annie Yu, Ph.D., speaks on the “How COVID-19 Changed Clinical Trial Dynamics and Environment” panel on January 27.
CRI's Jill O'Donnell-Tormey, Ph.D., moderates the cancer immunotherapy panel on November 10, 2020, at 10:35 AM ET.
CRI's Jill O'Donnell-Tormey, Ph.D., speaks on the "Public-Private Partnerships Between Research Organizations and BioPharma to Accelerate Cancer Immunotherapies" panel on October 2, 2020, at 1 PM ET.
CRI's Jill O'Donnell-Tormey, Ph.D., speaks on the "ESMO Post-Show" webinar on September 22, 2020, at 3 PM ET.
The Focused Ultrasound Foundation (FUSF) hosts a special conversation with Jill O’Donnell-Tormey, Ph.D., CEO of the Cancer Research Institute (CRI), and Jessica Foley, Ph.D., chief scientific officer of FUSF.
CRI's Vanessa Lucey, Ph.D., MBA, speaks on the "ASCO Preview" webinar on May 27, 2020, at 3 p.m. ET.
CRI's Vanessa Lucey, Ph.D., MBA, speaks on the "Investor Panel" on May 27, 2020, at 12 p.m. CT.
CRI's Vanessa Lucey, Ph.D., MBA, speaks on the "Investing into Oncology" and "Oncology Modalities Facing Off" panels.
CRI’s Vanessa Lucey, Ph.D., MBA, speaks on the "Landscape and Evolution of the Marketplace" panel on February 27, 2020.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
This Black History Month, meet a few Black leaders who have contributed to our understanding of the science of the immune system—and its protection against diseases, including cancer.
CRI experts share their latest insights on COVID-19 and cancer.